K2M Reports Preliminary 2016/4Q16 Revenue
K2M announced preliminary 2016 sales in the range of US $236.1MM to $236.6MM, and a 4Q16 sales range of $61.3MM to $61.8MM. (U.S. +21%, ex-U.S. -7%)
For 4Q16, approximate U.S. segment YoY growth is expected to be:
- Complex Spine +17%
- Minimally Invasive Spine +35%
- Degenerative +18%
The company expects to grow 2017 revenue in the mid-teens.
Source: K2M, Inc.